Skip to content

Vir Biotechnology, Inc.

VIR

CIK 0001706431

← back to feed
Revenue (TTM)
$6.87M
−7.6% YoY Q1 Apr 2026
Net Income (TTM)
−$520.76M
+16.1% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.70
+17.5% YoY Q1 Apr 2026
Gross Margin
98.4%
Q1 Apr 2026
Operating Margin
-8,210.0%
Q1 Apr 2026
Net Margin
-7,584.6%
Q1 Apr 2026
Free Cash Flow (TTM)
−$456.43M
Q1 Apr 2026
Cash
$274.16M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
168.65M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings